Roche Holding AG (0QQ6.L) LSE

300.80

+1.802(+0.60%)

Updated at October 03 02:06PM

Currency In CHF

Roche Holding AG

Address

Konzern Hauptsitz

Basel, 4070

Switzerland

Phone

41 61 688 11 11

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

103249

First IPO Date

March 07, 2014

Key Executives

NameTitlePayYear Born
Dr. Thomas SchineckerGroup Chief Executive Officer3.87M1975
Ms. Cristina A. WilburChief People Officer2.92M1967
Dr. Alan HippeChief Financial Officer4.11M1967
Dr. Severin Schwan Ph.D.Executive Chairman7.51M1967
Dr. Bruno EschliHead of Investor Relations0N/A
Ms. Pascale SchmidtChief Compliance Officer01973
Dr. Nicolas DunantHead of Group Media Relations0N/A
Ms. Barbara SchadlerHead of Group Communications01962
Ms. Claudia BockstiegelGeneral Counsel01964
Mr. Boris L. ZaitraHead of Corporate Business Development01972

Description

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.